Home › Funds › FULTON BREAKEFIELD BROENNIMAN LLC › LLY

FULTON BREAKEFIELD BROENNIMAN LLC position in LLY

ELI LILLY & CO · Health Care

FULTON BREAKEFIELD BROENNIMAN LLC reported holding 29,651 shares of LLY (ELI LILLY & CO) in its Q3 2026 13F filing — a position valued at US$34.3M, representing 2.01% of its reported portfolio and ranking #12 among its reported holdings. FULTON BREAKEFIELD BROENNIMAN LLC has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

Latest position (Q3 2026)29.65K sh
Reported value held$34.31M
Portfolio Weight2.01%
First reportedQ3 2023
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How FULTON BREAKEFIELD BROENNIMAN LLC's LLY position evolved

FULTON BREAKEFIELD BROENNIMAN LLC first disclosed a stake in LLY in Q3 2023 at 56,637 shares (US$30.4M). The position peaked in Q2 2024 at 43,680 shares, worth US$39.5M. Across 13 filings, FULTON BREAKEFIELD BROENNIMAN LLC increased the stake 0 time(s), trimmed it 9 time(s) and left it unchanged 3 time(s). The most recent filing (Q3 2026) shows 29,651 shares valued at US$34.3M — a reduction of -374 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q3 2023 56.64K $30.42M New
Q4 2023 55.98K $32.63M Reduce
Q1 2024 43.93K $34.17M Reduce
Q2 2024 43.68K $39.55M Reduce
Q3 2024 42.72K $37.84M Reduce
Q4 2024 42.64K $32.92M Hold
Q1 2025 40.63K $33.56M Reduce
Q2 2025 40.49K $31.56M Hold
Q3 2025 39.59K $30.21M Reduce
Q4 2025 30.59K $32.87M Reduce
Q1 2026 30.56K $28.11M Hold
Q2 2026 30.02K $36.01M Reduce
Q3 2026 29.65K $34.31M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LLY and 13F data

LLY (ELI LILLY & CO) is a Health Care company. 36 other funds we track also report a position in LLY — the largest reported positions include LILLY ENDOWMENT INC (US$104.21B), Vanguard Group (US$88.09B), BlackRock Inc (US$81.01B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LLY

All LLY fund holders →

FAQ

How long has FULTON BREAKEFIELD BROENNIMAN LLC held LLY?

FULTON BREAKEFIELD BROENNIMAN LLC has disclosed LLY holdings in 13 of the last 13 reported quarters, going back to Q3 2023.

What is FULTON BREAKEFIELD BROENNIMAN LLC's current position in LLY?

As of Q3 2026, FULTON BREAKEFIELD BROENNIMAN LLC holds 29.65K shares of LLY (ELI LILLY & CO), valued at $34.31M, representing 2.01% of its reported portfolio and ranking #12.

Has FULTON BREAKEFIELD BROENNIMAN LLC been buying or selling LLY?

In the latest 13F filing (Q3 2026), FULTON BREAKEFIELD BROENNIMAN LLC reduced its position in LLY. The position peaked in Q2 2024 at 43.68K shares.

Which other funds hold LLY?

Other major institutional holders of LLY include LILLY ENDOWMENT INC, Vanguard Group, BlackRock Inc, among 36 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.